California Biotechnology & Pharmaceuticals

Amgen is a leading human therapeutics company in the biotechnology industry. For more than 25 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine. Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness. - [Read more]

B-Bridge is a highly unique biotechnology company with a special business model. The company was founded in 2000 by Hiro Masumoto former head of International Sales and Marketing at Clontech Laboratories. He envisioned B-Bridge as a conduit facilitating the exchange of life-science technology worldwide. Since then, the company has grown into the following three complimenting corporate units: B-Bridge originally began as a distributor of laboratory reagents from manufacturers in the United States into Japan and expanded its distribution channels worldwide. During this period, B-Bridge pioneered the distribution of cutting edge products in - [Read more]

BioSource™ provides a comprehensive suite of sensitive and specific ELISAs, Luminex® assays, recombinant proteins and antibodies for analysis of multiple proteins and pathways. Technology Transfer. If you have developed biological reagents which you believe are of interest to the research community, BioSource™, through its Technology Transfer Program, can help you make them more readily available. BioSource™ already has agreements with many individual scientists, universities, research institutes and biotechnology companies covering the commercialization of monoclonal and polyclonal antibodies, recombinant proteins, vectors, - [Read more]

Clinimetrics, Inc. is a global, full service contract research organization (CRO) that offers a complete array of integrated research services including clinical and data management, project management and biostatistics as well as quality assurance, regulatory and medical affairs. In addition, Clinimetrics also provides in-house staff, customized training programs, and an integrated travel and event planning services for meetings and corporate functions. With Corporate Headquarters in San Jose, California and Operation Centers located regionally in San Diego, California, Atlanta, Georgia, Mississauga, Toronto (Canada), Maidenhead, England and - [Read more]

Integrium is a full-service Clinical Research Organization (CRO) exclusively dedicated to the management of cardiovascular and metabolic disease clinical trials. We combine our focused clinical expertise with strong operational capabilities to deliver the highest level of customer care. Within our singular therapeutic focus, our vast trial experience spans across all stages of clinical development and stretches around the globe, from single region, proof-of-concept studies to multinational pivotal trials with more than 6,000 subjects. The impressive operational capacity and depth of experience of Integrium is a product of our years spent - [Read more]

International Immunology Corporation (IIC) provides high quality bulk polyclonal antisera and calibrators/controls. Our primary focus is quality bulk antisera, a raw material used in human diagnostic reagent kits. Our large scale manufacturing operations produce antisera and complementary items used for various test methodologies in clinical laboratories, commercial laboratories, research institutions, and hospitals. Dedication to meeting customer needs remains the heart of our business. Incorporating performance and competitive value in our products are just two ways in which we strive to meet those needs. Our catalog product lines - [Read more]

Maxygen is focused on the development of superior versions of validated major protein pharmaceuticals for the patients who need them. Our lead product candidates address substantial market opportunities in cancer, hemostatis, and rheumatoid arthritis. We are well positioned for growth with a number of excellent product candidates and the financial strength to drive them forward through clinical development. In 1997, Maxygen was founded on the observation that nature has a powerful means of improving upon previous generations through the iterative process of evolution and breeding. We have industrialized this evolutionary process by - [Read more]

Mendel Biotechnology, Inc. is a pioneer in the application of functional genomics to the study of plant genes. Mendels mission is to discover and characterize the function of important plant genes and to develop and commercialize high- value products based on these discoveries. Mendel is currently licensing WeatherGard genes. WeatherGard genes are regulatory genes that allow plants to be engineered to be more tolerant to drought, freezing, and high salt soils. Thus, they are proof of concept that regulatory genes control valuable agricultural traits. - [Read more]

Pharmacyclics is committed to improving the lives of patients with cancer and other serious diseases through research, development, and commercialization of novel small-molecule drugs. We have focused our development on innovative therapies that selectively target diseased cells through unique molecular pathways. Pharmacyclics is a pharmaceutical company developing innovative treatments for cancer and other diseases. The company is working on a range of clinical and laboratory programs and is pursuing the development of novel drugs aimed at specific disease pathways. The company's most advanced product candidate, - [Read more]

Sangamo BioSciences, Inc., is focused on the research and development of novel transcription factors for the regulation of gene expression. The company's most advanced therapeutic development program involves the use of transcription factors for the treatment of cardiovascular disease. Other therapeutics development programs are focused on cancer, neuropathic pain, ophthalmic and infectious diseases. Sangamo's proprietary technology enables the engineering of transcription factors known as zinc finger DNA-binding proteins, or ZFPs. By engineering ZFPs so that they can recognize a specific gene, Sangamo has created ZFP transcription - [Read more]

TeleChem International, Inc., was founded in 1993 by Rene' Schena and Todd Martinsky as a chemical import and export trading company. TeleChem’s Chemicals Division continues to expand and diversify, providing customers with the raw materials required for plastics, water soluble fertilizers, and alternative fuels. After four years of solid success in the chemicals market, we turned our expansion efforts to the biotechnology sector, giving rise to the ArrayIt® Life Sciences Division in 1996. With the fervor over the Human Genome Project and the rise of microarray technology, we anticipated a demand for microarray products and services - [Read more]